Skip to main content

September 2024

academics

 

Clinical research courses

Interview for B.Pharm at Homi Bhabha Cancer Hospital & Research Centre

B.Pharm with degree, diploma in Clinical Research Methodology. The candidate with a minimum 1 year experience in conducting clinical trial will be given preference.
Pharma Recruitment at Institute of Microbial Technology
Masters in Natural or Agricultural or Pharmaceutical Sciences, MVSc, Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University
Career for Assistant Professor at Central University of Rajasthan, Salary Rs. 50,000 pm
A basic degree in Pharmacy Registration as Pharmacist under Pharmacy act 1948, as amended from time to time, including any succeeding enactments
Career for Life Sciences candidates at BRIC-THSTI | Salary upto Rs. 1 lakh pm
Ph.D or corresponding degree in any area of Life Sciences, Medical Sciences with one year of post-qualification research experience.
ICMR looking for Coordinator, Data Scientist at Division of Non Communicable Diseases
First Class Post Graduate Degree, including the integrated PG degree in Science, Public Health, Life Sciences OR Second Class Post Graduate Degree, including the integrated PG degree with PhD Science, Public Health, Life Sciences
Opportunity for Research Associate to Join IISER, Salary Rs. 63,220 pm
Ph.D. degree in Plant Biology, Molecular Biology, Computational Biology with prior plant science research experience. Candidates who have submitted their thesis and awaiting the award of Ph.D. Degree may also apply. 
Walk in Drive for B.Pharm, MSc in Production Department at Senores Pharmaceuticals
Demonstrate expertise in tablet and capsule manufacturing processes, including granulation, compression, coating, and filling. Operate production equipment such as MG, FBD, compression machines, coaters, and capsule filling machines.
Require SERM Scientific Director at GSK
Leads Pharmacovigilance and Risk Management Planning and develops strategy for approach to evaluation of issues in the clinical matrix. Leads the safety component of global regulatory submissions.
FDA approves Drug with New Mechanism of Action for Treatment of Schizophrenia

The U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.

Torrent Pharma refutes claims of Shelcal 500 allegedly failing CDSCO quality test
Recent articles have been issued in media with reference to the Central Drugs Standard Control Organization East Zone, Kolkata report referring to one batch sample of Product Shelcal 500, amongst other drugs marketed by various pharmaceutical companies, allegedly being non-standard quality.